<?xml version='1.0' encoding='utf-8'?>
<document id="31678583"><sentence text="Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy." /><sentence text="Epilepsy is a complex network phenomenon that, as yet, cannot be prevented or cured" /><sentence text=" We recently proposed network-based approaches to prevent epileptogenesis" /><sentence text=" For proof of concept we combined two drugs (levetiracetam and topiramate) for which in silico analysis of drug-protein interaction networks indicated a synergistic effect on a large functional network of epilepsy-relevant proteins"><entity charOffset="45-58" id="DDI-PubMed.31678583.s4.e0" text="levetiracetam" /><entity charOffset="63-73" id="DDI-PubMed.31678583.s4.e1" text="topiramate" /><pair ddi="false" e1="DDI-PubMed.31678583.s4.e0" e2="DDI-PubMed.31678583.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31678583.s4.e0" e2="DDI-PubMed.31678583.s4.e1" /></sentence><sentence text=" Using the intrahippocampal kainate mouse model of temporal lobe epilepsy, the drug combination was administered during the latent period before onset of spontaneous recurrent seizures (SRS)" /><sentence text=" When SRS were periodically recorded by video-EEG monitoring after termination of treatment, a significant decrease in incidence and frequency of SRS was determined, indicating antiepileptogenic efficacy" /><sentence text=" Such efficacy was not observed following single drug treatment" /><sentence text=" Furthermore, a combination of levetiracetam and phenobarbital, for which in silico analysis of drug-protein interaction networks did not indicate any significant drug-drug interaction, was not effective to modify development of epilepsy"><entity charOffset="31-44" id="DDI-PubMed.31678583.s8.e0" text="levetiracetam" /><entity charOffset="49-62" id="DDI-PubMed.31678583.s8.e1" text="phenobarbital" /><pair ddi="false" e1="DDI-PubMed.31678583.s8.e0" e2="DDI-PubMed.31678583.s8.e0" /><pair ddi="false" e1="DDI-PubMed.31678583.s8.e0" e2="DDI-PubMed.31678583.s8.e1" /></sentence><sentence text=" Surprisingly, the promising antiepileptogenic effect of the levetiracetam/topiramate combination was obtained in the absence of any significant neuroprotective or anti-inflammatory effects as indicated by multimodal brain imaging and histopathology"><entity charOffset="61-74" id="DDI-PubMed.31678583.s9.e0" text="levetiracetam" /><entity charOffset="75-85" id="DDI-PubMed.31678583.s9.e1" text="topiramate" /><pair ddi="false" e1="DDI-PubMed.31678583.s9.e0" e2="DDI-PubMed.31678583.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31678583.s9.e0" e2="DDI-PubMed.31678583.s9.e1" /></sentence><sentence text=" High throughput RNA-sequencing (RNA-seq) of the ipsilateral hippocampus of mice treated with the levetiracetam/topiramate combination showed that several genes that have been linked previously to epileptogenesis, were significantly differentially expressed, providing interesting entry points for future mechanistic studies"><entity charOffset="98-111" id="DDI-PubMed.31678583.s10.e0" text="levetiracetam" /><entity charOffset="112-122" id="DDI-PubMed.31678583.s10.e1" text="topiramate" /><pair ddi="false" e1="DDI-PubMed.31678583.s10.e0" e2="DDI-PubMed.31678583.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31678583.s10.e0" e2="DDI-PubMed.31678583.s10.e1" /></sentence><sentence text=" Overall, we have discovered a novel combination treatment with promise for prevention of epilepsy" /><sentence text="" /></document>